Hims & Hers Health (HIMS) Cash & Equivalents (2019 - 2026)
Hims & Hers Health's Cash & Equivalents history spans 8 years, with the latest figure at $222.3 million for Q1 2026.
- On a quarterly basis, Cash & Equivalents fell 18.8% to $222.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $222.3 million, a 18.8% decrease, with the full-year FY2025 number at $228.6 million, up 3.64% from a year prior.
- Cash & Equivalents hit $222.3 million in Q1 2026 for Hims & Hers Health, down from $228.6 million in the prior quarter.
- Over the last five years, Cash & Equivalents for HIMS hit a ceiling of $1.1 billion in Q2 2025 and a floor of $46.8 million in Q4 2022.
- Historically, Cash & Equivalents has averaged $193.7 million across 5 years, with a median of $105.2 million in 2024.
- Biggest five-year swings in Cash & Equivalents: plummeted 48.64% in 2022 and later skyrocketed 769.78% in 2025.
- Tracing HIMS's Cash & Equivalents over 5 years: stood at $46.8 million in 2022, then surged by 106.67% to $96.7 million in 2023, then surged by 128.2% to $220.6 million in 2024, then increased by 3.64% to $228.6 million in 2025, then dropped by 2.78% to $222.3 million in 2026.
- Business Quant data shows Cash & Equivalents for HIMS at $222.3 million in Q1 2026, $228.6 million in Q4 2025, and $345.8 million in Q3 2025.